Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Volume XXXII, No. 14 - October 6, 2025

After Regaining its Outreach Service, Lab Grows It by $10M

TDR Insider / Robert Michel

In this case study, Kootenai Health in Idaho explains how taking back lab outreach services from a commercial lab company can improve physician satisfaction, enhance patient care, and increase revenue. Although the transition was bumpy, within two years of bringing outreach in house, those services contributed $10 million to the health system’s bottom line. This […]

To access this post, you must purchase The Dark Report.

After Regaining its Outreach Service, Lab Grows It by $10M Read More »

Observing a Champion … and Some Antagonists

Commentary and Opinion by R. Lewis Dark / R. Lewis Dark

Judging from the briefings we present in this issue, a “cheers and jeers” column seems an appropriate use of my soapbox. First, the well-earned cheers. An in-depth case study traces how Kootenai Health, which had seen its clinical laboratory outreach business outsourced to a national lab, took a series of strategic steps to win back

To access this post, you must purchase The Dark Report.

Observing a Champion … and Some Antagonists Read More »

Employer Healthcare Costs Will Rise in 2026

Clinical Laboratory Trends / Janette Wider

CEO SUMMARY: Private employers face the highest increase in health benefit costs per employee since 2010. Advances in therapeutics, including popular obesity drugs, and increased utilization are among the culprits. Savvy clinical laboratories will recognize the opportunity to partner with companies to drive down costs through testing and better monitoring of employee health conditions and

To access this post, you must purchase The Dark Report.

Employer Healthcare Costs Will Rise in 2026 Read More »

After Regaining Outreach, Lab Grows it by $10M

Laboratory Management / Janette Wider

CEO SUMMARY: In this case study, Kootenai Health in Idaho explains how taking back lab outreach services from a commercial lab company can improve physician satisfaction, enhance patient care, and increase revenue. Although the transition was bumpy, within two years of bringing outreach in house, those services contributed $10 million to the health system’s bottom

To access this post, you must purchase The Dark Report.

After Regaining Outreach, Lab Grows it by $10M Read More »

Could AI Oversight in Labs Fall Under a CLIA Model?

Clinical Laboratory Trends / Scott Wallask

CEO SUMMARY: Clinical AI is advancing faster than regulation, creating risk for medical labs. An expert discusses using CLIA to oversee development and ensure safety, performance, and accountability while complementing FDA oversight. Lab leaders face regulatory uncertainty and vendor pushback, making up-front engagement and internal accountability critical for adopting AI while maintaining competitive advantage. Clinical

To access this post, you must purchase The Dark Report.

Could AI Oversight in Labs Fall Under a CLIA Model? Read More »

New Study Underscores Prevalence of Scientific Fraud

Pathology Trends / Stephen Beale

Pathologists and other laboratory professionals rely on peer-reviewed research to keep up with the latest developments in their specialties. They do so with the expectation that medical journals are upholding high standards of scientific rigor and transparency. It should thus be of grave concern when bad actors manipulate academic publishing systems to perpetrate scientific fraud.

To access this post, you must purchase The Dark Report.

New Study Underscores Prevalence of Scientific Fraud Read More »

After SALSA Hits a Wall, New RESULTS Act Steps In

Laboratory Compliance / Scott Wallask

Upon reading the briefing in the last issue about the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act, someof our members may have wondered,“What happened to SALSA?” SALSA, more formally known as the Saving Access to Laboratory Services Act, had been touted as a path to reform the Protecting Access to Medicare

To access this post, you must purchase The Dark Report.

After SALSA Hits a Wall, New RESULTS Act Steps In Read More »

Lumea’s Digital Pathology Success Lands It on Inc. 5000

Digital Pathology / Scott Wallask

Digital pathology company Lumea was perhaps the most notable entry from the clinical laboratory world to make it onto the Inc. 5000 list of the fastest growing private companies in America in 2025. Lumea placed mid-pack at No. 2,468 in the ranking. Editors at Inc. noted that the company has enjoyed 173% growth over the

To access this post, you must purchase The Dark Report.

Lumea’s Digital Pathology Success Lands It on Inc. 5000 Read More »

National Lab Company Briefs

Laboratory Management / Scott Wallask

Quest, Labcorp Push Alzheimer’s Test Quest Diagnostics and Labcorp are now offering Fujirebio’s Lumipulse test, the first Food and Drug Administration-cleared blood-based assay for confirming Alzheimer’s disease in patients over age 50 with mild cognitive decline. The test offers a less invasive and more affordable alternative to PET scans or spinal taps. Early diagnosis of

To access this post, you must purchase The Dark Report.

National Lab Company Briefs Read More »

October 6, 2025, Intelligence: Late-Breaking Lab News

Late Breaking Lab News / Robert Michel

Bloomberg News has reported that Siemens Healthineers is potentially exploring a sale of its diagnostics division. Several large private equity firms have held early talks with Siemens, including Blackstone, CVC Capital Partners, and KKR & Co., according to Bloomberg. Sources indicated to the news outlet that the diagnostics arm could be valued at $7 billion.

To access this post, you must purchase The Dark Report.

October 6, 2025, Intelligence: Late-Breaking Lab News Read More »

;